Cochrane Abstracts
Ketamine for management of acute exacerbations of asthma in children Edited (no change to conclusions)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Ketamine for Management of Acute Exacerbations of Asthma in Children Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436698/all/Laquinimod_for_multiple_sclerosis:_Cochrane_systematic_review. Accessed 06 June 2023.
Ketamine for management of acute exacerbations of asthma in children Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436698/all/Laquinimod_for_multiple_sclerosis:_Cochrane_systematic_review. Accessed June 6, 2023.
Ketamine for management of acute exacerbations of asthma in children Edited (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436698/all/Laquinimod_for_multiple_sclerosis:_Cochrane_systematic_review
Ketamine for Management of Acute Exacerbations of Asthma in Children Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2023 June 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436698/all/Laquinimod_for_multiple_sclerosis:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ketamine for management of acute exacerbations of asthma in children Edited (no change to conclusions)
ID - 436698
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436698/all/Laquinimod_for_multiple_sclerosis:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
